Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Liposome-Targeted Delivery for Highly Potent Drugs Publisher Pubmed



Bardania H1 ; Tarvirdipour S2 ; Dorkoosh F3, 4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Cellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran
  2. 2. Biomedical Division, Faculty of Chemical Engineering, Tarbiat Modares University, Tehran, Iran
  3. 3. Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Medical Biomaterial Research Center (MBRC), Tehran University of Medical Sciences, Tehran, Iran

Source: Artificial Cells# Nanomedicine and Biotechnology Published:2017


Abstract

Considerable adverse side effects and cytotoxicity of highly potent drugs for healthy tissue require the development of novel drug delivery systems to improve pharmacokinetics and result in selective distribution of the loaded agent. The introduction of targeted liposomal formulations has provided potential solutions for improved drug delivery to cancer cells, penetrating delivery through blood–brain barrier and gene therapy. A large number of investigations have been developed over the past few decades to overcome pharmacokinetics and unfavorable side effects limitations. These improvements have enabled targeted liposome to meet criteria for successful and improved potent drug targeting. Promising in vitro and in vivo results for liposomal-directed delivery systems appear to be effective for vast variety of highly potent therapeutics. This review will focus on the past decade’s potential use and study of highly potent drugs using targeted liposomes. © 2017 Informa UK Limited, trading as Taylor & Francis Group.
Related Docs
View other Related Docs
1. Transferrin Receptor-Mediated Liposomal Drug Delivery: Recent Trends in Targeted Therapy of Cancer, Expert Opinion on Drug Delivery (2022)
2. Functionalized Liposomes As Drug Nanocarriers for Active Targeted Cancer Therapy: A Systematic Review, Journal of Liposome Research (2022)
3. 5Tr1 Aptamer-Pegylated Liposomal Doxorubicin Enhances Cellular Uptake and Suppresses Tumour Growth by Targeting Muc1 on the Surface of Cancer Cells, Artificial Cells# Nanomedicine and Biotechnology (2018)
4. What We Need to Know About Liposomes As Drug Nanocarriers: An Updated Review, Advanced Pharmaceutical Bulletin (2023)
5. A Concise Review on Cancer Treatment Methods and Delivery Systems, Journal of Drug Delivery Science and Technology (2019)
6. Improved Drug Delivery and Therapeutic Efficacy of Pegylated Liposomal Doxorubicin by Targeting Anti-Her2 Peptide in Murine Breast Tumor Model, European Journal of Pharmaceutical Sciences (2016)
7. Application of Nano-Based Systems for Drug Delivery and Targeting: A Review, Journal of Nanoparticle Research (2020)
8. A Review on Liposome-Based Therapeutic Approaches Against Malignant Melanoma, International Journal of Pharmaceutics (2021)
Experts (# of related papers)
View all Related Experts
Farid Dorkoosh (10)
Somayeh Handali (7)
Other Related Docs
9. Co-Delivery Systems: Hope for Clinical Application?, Drug Delivery and Translational Research (2022)
10. Nanoparticles and Targeted Drug Delivery in Cancer Therapy, Immunology Letters (2017)
11. Liposomes, New Carriers for Delivery of Genes and Anticancer Drugs: A Systematic Review, Anti-Cancer Drugs (2022)
12. Biodegradable Nano-Polymers As Delivery Vehicles for Therapeutic Small Non-Coding Ribonucleic Acids, Journal of Controlled Release (2017)
13. Recent Progress in Biomedical Applications of Rgd-Based Ligand: From Precise Cancer Theranostics to Biomaterial Engineering: A Systematic Review, Journal of Biomedical Materials Research - Part A (2020)
14. Targeting Sirna in Colorectal Cancer Therapy: Nanotechnology Comes Into View, Journal of Cellular Physiology (2019)
15. Encapsulation of Eptifibatide in Rgd-Modified Nanoliposomes Improves Platelet Aggregation Inhibitory Activity, Journal of Thrombosis and Thrombolysis (2017)
16. Targeted Cancer Therapy Through Antibody Fragments-Decorated Nanomedicines, Journal of Controlled Release (2017)
17. An Update on Actively Targeted Liposomes in Advanced Drug Delivery to Glioma, International Journal of Pharmaceutics (2021)
18. Hydrogel-Mediated Delivery of Microrna-92A Inhibitor Polyplex Nanoparticles Induces Localized Angiogenesis, Angiogenesis (2021)
19. Liposomes: Structure, Biomedical Applications, and Stability Parameters With Emphasis on Cholesterol, Frontiers in Bioengineering and Biotechnology (2021)
20. Cell Targeting Peptides As Smart Ligands for Targeting of Therapeutic or Diagnostic Agents: A Systematic Review, Colloids and Surfaces B: Biointerfaces (2017)
21. Potential Application of Liposomal Nanodevices for Non-Cancer Diseases: An Update on Design, Characterization and Biopharmaceutical Evaluation, Advances in Colloid and Interface Science (2020)
22. Potential Anticancer Activity of a New Pro-Apoptotic Peptide-Thioctic Acid Gold Nanoparticle Platform, Nanotechnology (2021)
23. Nanoliposome Encapsulated Anesthetics for Local Anesthesia Application, Biomedicine and Pharmacotherapy (2017)
24. Nano-Scale Delivery Systems for Sirna Delivery in Cancer Therapy: New Era of Gene Therapy Empowered by Nanotechnology, Environmental Research (2023)
25. Smart External Stimulus-Responsive Nanocarriers for Drug and Gene Delivery, Smart External Stimulus-Responsive Nanocarriers for Drug and Gene Delivery (2015)
26. Inhibiting Influenza Virus Replication and Inducing Protection Against Lethal Influenza Virus Challenge Through Chitosan Nanoparticles Loaded by Sirna, Drug Delivery and Translational Research (2018)
27. Transferrin Targeted Liposomal 5-Fluorouracil Induced Apoptosis Via Mitochondria Signaling Pathway in Cancer Cells, Life Sciences (2018)
28. Folic Acid-Modified Liposomal Drug Delivery Strategy for Tumor Targeting of 5-Fluorouracil, European Journal of Pharmaceutical Sciences (2018)
29. Nanomedicine and Chemotherapeutics Drug Delivery: Challenges and Opportunities, Journal of Drug Targeting (2021)
30. Recent Advances on High-Efficiency of Micrornas in Different Types of Lung Cancer: A Comprehensive Review, Cancer Cell International (2023)
31. A Mechanistic Study of the Effect of Transferrin Conjugation on Cytotoxicity of Targeted Liposomes, Journal of Microencapsulation (2018)
32. An Overview on Display Systems (Phage, Bacterial, and Yeast Display) for Production of Anticancer Antibodies; Advantages and Disadvantages, International Journal of Biological Macromolecules (2022)
33. Nanostructures for Site-Specific Delivery of Oxaliplatin Cancer Therapy: Versatile Nanoplatforms in Synergistic Cancer Therapy, Translational Oncology (2024)
34. New Methods in the Diagnosis of Cancer and Gene Therapy of Cancer Based on Nanoparticles, Cancer Gene Therapy (2017)
35. A Novel 5-Fluorouracil Targeted Delivery to Colon Cancer Using Folic Acid Conjugated Liposomes, Biomedicine and Pharmacotherapy (2018)
36. Hyaluronic Acid-Coated Liposomes for Targeted Delivery of Paclitaxel, In-Vitro Characterization and In-Vivo Evaluation, Journal of Controlled Release (2016)
37. Nanobodies As Novel Agents for Targeting Angiogenesis in Solid Cancers, Frontiers in Immunology (2017)
38. A Review on the Role of Lipid-Based Nanoparticles in Medical Diagnosis and Imaging, Therapeutic Delivery (2018)
39. Co-Delivery of Mir-181A and Melphalan by Lipid Nanoparticles for Treatment of Seeded Retinoblastoma, Journal of Controlled Release (2019)
40. Ph-Sensitive Pegylated Liposomal Silybin: Synthesis, in Vitro and in Vivo Anti-Tumor Evaluation, Journal of Pharmaceutical Sciences (2021)
41. Stimuli-Responsive Mesoporous Silica Nps As Non-Viral Dual Sirna/Chemotherapy Carriers for Triple Negative Breast Cancer, Molecular Therapy Nucleic Acids (2017)
42. Nanoparticle-Sirna: A Potential Strategy for Ovarian Cancer Therapy?, Nanomedicine (2019)
43. Optimization of Rgd-Modified Nano-Liposomes Encapsulating Eptifibatide, Iranian Journal of Biotechnology (2016)
44. Cancer Nanomedicine: Special Focus on Cancer Immunotherapy, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
45. Rgd-Engineered Nanoparticles As an Innovative Drug Delivery System in Cancer Therapy, Journal of Drug Delivery Science and Technology (2023)
46. Current Advances and Challenges in Covid-19 Vaccine Development: From Conventional Vaccines to Next-Generation Vaccine Platforms, Molecular Biology Reports (2022)
47. Optimization of Docetaxel Loading Conditions in Liposomes: Proposing Potential Products for Metastatic Breast Carcinoma Chemotherapy, Scientific Reports (2020)
48. Biomedical Applications of Intelligent Nanomaterials, Intelligent Nanomaterials: Second Edition (2016)
49. Novel Polyurethane-Based Ionene Nanoparticles Electrostatically Stabilized With Hyaluronic Acid for Effective Gene Therapy, Colloids and Surfaces B: Biointerfaces (2024)
50. Cationic Liposome Decorated With Cyclic Rgd Peptide for Targeted Delivery of Anti-Stat3 Sirna to Melanoma Cancer Cells, Journal of Drug Targeting (2022)